These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 10961773)
1. Sumatriptan nasal spray in the acute treatment of migraine: a review of clinical studies. Tfelt-Hansen P Cephalalgia; 2000 Mar; 20(2):137. PubMed ID: 10961773 [No Abstract] [Full Text] [Related]
2. A clinical comparison of sumatriptan nasal spray and dihydroergotamine nasal spray in the acute treatment of migraine. Boureau F; Kappos L; Schoenen J; Esperanca P; Ashford E Int J Clin Pract; 2000 Jun; 54(5):281-6. PubMed ID: 10954953 [TBL] [Abstract][Full Text] [Related]
3. [Treatment of the acute migraine attack]. Titus F Rev Neurol; 1995; 23 Suppl 2():S203-7. PubMed ID: 7497289 [No Abstract] [Full Text] [Related]
4. Transient global amnesia, migraine, thalamic infarct, dihydroergotamine, and sumatriptan. Pradalier A; Lutz G; Vincent D Headache; 2000 Apr; 40(4):324-7. PubMed ID: 10759939 [TBL] [Abstract][Full Text] [Related]
5. [Improper equalization of sumatriptan with ergotamine and dihydroergotamine in the Drug Equivalency System]. Ferrari MD; Haan J; Bax WA; van Coevorden RS; Timmerman H; Meijler WJ Ned Tijdschr Geneeskd; 1993 Apr; 137(17):846-50. PubMed ID: 8387648 [No Abstract] [Full Text] [Related]
7. [Unjustified equalization of sumatriptan with ergotamine and dihydroergotamine in the Drug Equivalency System]. Van Mil JW Ned Tijdschr Geneeskd; 1993 Jun; 137(24):1213-4. PubMed ID: 8391659 [No Abstract] [Full Text] [Related]
8. Sumatriptan nasal spray for migraine: a review of studies in patients aged 17 years and younger. Hämäläinen M; Jones M; Loftus J; Saiers J Int J Clin Pract; 2002 Nov; 56(9):704-9. PubMed ID: 12469987 [TBL] [Abstract][Full Text] [Related]
9. [Sumatriptan nasal spray 20mg: efficacy, tolerance and quality of life in migraine patients]. Géraud G; Valette C Rev Neurol (Paris); 2000 Jul; 156(6-7):646-53. PubMed ID: 10891800 [TBL] [Abstract][Full Text] [Related]
10. [The treatment of migraine]. Titus F Rev Neurol; 1997 Feb; 25(138):295-300. PubMed ID: 9147762 [No Abstract] [Full Text] [Related]
11. Comparing dihydroergotamine mesylate and sumatriptan in the management of acute migraine. A retrospective cost-efficacy analysis. Payne K; Kozma CM; Lawrence BJ Pharmacoeconomics; 1996 Jul; 10(1):59-71. PubMed ID: 10160470 [TBL] [Abstract][Full Text] [Related]
12. [Drug-clinics. The drug of the month. Imitrex nasal spray (sumatriptan)]. Scheen AJ Rev Med Liege; 1997 Sep; 52(9):610-2. PubMed ID: 9441347 [No Abstract] [Full Text] [Related]
13. [Pharmacologic treatment of acute migraine attack in children]. Cuvellier JC; Joriot S; Auvin S; Vallée L Arch Pediatr; 2005 Mar; 12(3):316-25. PubMed ID: 15734131 [TBL] [Abstract][Full Text] [Related]
14. A new dihydroergotamine nasal spray (Trudhesa) for migraine. Med Lett Drugs Ther; 2021 Dec; 63(1640):204-207. PubMed ID: 35100240 [No Abstract] [Full Text] [Related]
15. Serotonin 1D (5-HT1D) agonists and other agents in acute migraine. Mathew NT Neurol Clin; 1997 Feb; 15(1):61-83. PubMed ID: 9058397 [TBL] [Abstract][Full Text] [Related]
16. Dihydroergotamine, ergotamine, methysergide and sumatriptan - basic science in relation to migraine treatment. Dahlöf C; Maassen Van Den Brink A Headache; 2012 Apr; 52(4):707-14. PubMed ID: 22444161 [TBL] [Abstract][Full Text] [Related]
17. Does the presence of aura inform us regarding migraine severity and response to treatment? Ward TN Neurology; 2015 May; 84(18):1828-9. PubMed ID: 25841027 [No Abstract] [Full Text] [Related]